$202 Million is the total value of Sio Capital Management, LLC's 39 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 130.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | New | GILEAD SCIENCES ORDput | $58,540,000 | – | 500,000 | +100.0% | 28.92% | – |
| QTNT | Sell | QUOTIENT ORD | $16,165,000 | -15.4% | 1,092,991 | -2.7% | 7.99% | -26.5% |
| GSK | New | GLAXOSMITHKLINE ORDadr | $10,621,000 | – | 255,000 | +100.0% | 5.25% | – |
| RXDX | New | IGNYTA ORD | $7,888,000 | – | 522,756 | +100.0% | 3.90% | – |
| FLML | New | FLAMEL TECHNOLOGIES ADR REP 1 ORDadr | $6,781,000 | – | 320,000 | +100.0% | 3.35% | – |
| PFNX | Sell | PFENEX ORD | $6,715,000 | -35.5% | 346,128 | -47.0% | 3.32% | -44.0% |
| JNJ | Buy | JOHNSON & JOHNSON ORD | $6,255,000 | +38.2% | 64,177 | +42.6% | 3.09% | +20.0% |
| PETX | Buy | ARATANA THERAPEUTICS ORD | $6,120,000 | +114.1% | 404,738 | +126.7% | 3.02% | +85.9% |
| CAH | Buy | CARDINAL HEALTH ORD | $5,293,000 | +1.1% | 63,278 | +9.1% | 2.62% | -12.2% |
| ADUS | Sell | ADDUS HOMECARE ORD | $5,183,000 | +18.8% | 186,055 | -1.8% | 2.56% | +3.2% |
| ADMP | Buy | ADAMIS PHARMACEUTICALS ORD | $5,133,000 | +10.4% | 1,222,260 | +3.6% | 2.54% | -4.2% |
| AET | New | AETNA ORD | $5,098,000 | – | 40,000 | +100.0% | 2.52% | – |
| PFE | New | PFIZER ORDput | $5,030,000 | – | 150,000 | +100.0% | 2.48% | – |
| AMGN | New | AMGEN ORD | $4,352,000 | – | 28,349 | +100.0% | 2.15% | – |
| HNGR | New | HANGER ORD | $4,122,000 | – | 175,859 | +100.0% | 2.04% | – |
| MDT | New | MEDTRONIC ORD | $4,105,000 | – | 55,400 | +100.0% | 2.03% | – |
| ASND | New | ASCENDIS PHARMA ADR REP ORDadr | $3,581,000 | – | 202,525 | +100.0% | 1.77% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS ORD | $3,236,000 | – | 27,000 | +100.0% | 1.60% | – |
| SYK | New | STRYKER ORD | $3,182,000 | – | 33,300 | +100.0% | 1.57% | – |
| JNJ | Sell | JOHNSON & JOHNSON ORDput | $2,924,000 | -41.9% | 30,000 | -40.0% | 1.44% | -49.5% |
| IRWD | New | IRONWOOD PHARMA CL A ORD | $2,858,000 | – | 237,000 | +100.0% | 1.41% | – |
| CI | New | CIGNA ORD | $2,858,000 | – | 17,640 | +100.0% | 1.41% | – |
| IMMU | New | IMMUNOMEDICS ORDput | $2,699,000 | – | 664,900 | +100.0% | 1.33% | – |
| LLY | Sell | ELI LILLY ORDput | $2,505,000 | -65.5% | 30,000 | -70.0% | 1.24% | -70.1% |
| ABT | New | ABBOTT LABORATORIES ORDput | $2,454,000 | – | 50,000 | +100.0% | 1.21% | – |
| HYH | New | HALYARD HEALTH ORD | $2,430,000 | – | 60,000 | +100.0% | 1.20% | – |
| ABBV | Sell | ABBVIE ORD | $2,237,000 | -30.5% | 33,291 | -39.5% | 1.10% | -39.7% |
| MDT | New | MEDTRONIC ORDput | $2,223,000 | – | 30,000 | +100.0% | 1.10% | – |
| ACHN | New | ACHILLION PHARMACEUTICALS ORD | $2,188,000 | – | 247,000 | +100.0% | 1.08% | – |
| GSK | New | GLAXOSMITHKLINE ADR REP TWO ORDput | $2,082,000 | – | 50,000 | +100.0% | 1.03% | – |
| ANTH | New | ANTHERA PHARMACEUTICALS ORD | $2,053,000 | – | 238,158 | +100.0% | 1.01% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS ORD | $1,653,000 | – | 161,286 | +100.0% | 0.82% | – |
| SCYX | Buy | SCYNEXIS ORD | $1,426,000 | +12.5% | 162,175 | +6.1% | 0.70% | -2.4% |
| NSPR | Sell | INSPIREMD ORD | $607,000 | -14.9% | 2,166,446 | -2.7% | 0.30% | -26.1% |
| AGRX | Sell | AGILE THERAPEUTICS ORD | $538,000 | -71.5% | 62,592 | -69.3% | 0.27% | -75.3% |
| KMPH | New | KEMPHARM ORD | $506,000 | – | 27,543 | +100.0% | 0.25% | – |
| HART | Sell | HARVARD APPARATUS REGENERATIVE ORD | $333,000 | -77.5% | 232,712 | -49.0% | 0.16% | -80.4% |
| MRTX | Sell | MIRATI THERAPEUTICS ORD | $252,000 | -81.6% | 8,008 | -82.8% | 0.12% | -84.0% |
| BIOD | New | BIODEL ORD | $165,000 | – | 160,523 | +100.0% | 0.08% | – |
| BDSI | Exit | BIODELIVERY SCIENCE INTERNATIONLcall | $0 | – | -169,200 | -100.0% | -0.11% | – |
| MMSI | Exit | MERIT MEDICAL SYSTEMS | $0 | – | -24,235 | -100.0% | -0.27% | – |
| TKAI | Exit | TOKAI PHARMACEUTICALS | $0 | – | -82,283 | -100.0% | -0.53% | – |
| TGTX | Exit | TG THERAPEUTICS | $0 | – | -76,924 | -100.0% | -0.68% | – |
| FWP | Exit | FORWARD PHARMA ADR REP 1adr | $0 | – | -67,455 | -100.0% | -1.09% | – |
| HRTX | Exit | HERON THERAPEUTICS | $0 | – | -137,100 | -100.0% | -1.14% | – |
| STML | Exit | STEMLINE THERAPEUTICS | $0 | – | -140,000 | -100.0% | -1.15% | – |
| GTS | Exit | TRIPLE S MANAGEMENT CL B | $0 | – | -112,400 | -100.0% | -1.27% | – |
| CLDN | Exit | CELLADONput | $0 | – | -138,800 | -100.0% | -1.50% | – |
| UNH | Exit | UNITEDHEALTH GRP | $0 | – | -26,500 | -100.0% | -1.78% | – |
| CERN | Exit | CERNERput | $0 | – | -53,800 | -100.0% | -2.24% | – |
| UTHR | Exit | UNITED THERAPEUTICS | $0 | – | -34,700 | -100.0% | -3.40% | – |
| AZN | Exit | ASTRAZENECA ADR REP 1put | $0 | – | -100,000 | -100.0% | -3.89% | – |
| MRK | Exit | MERCK & CO | $0 | – | -145,000 | -100.0% | -4.74% | – |
| CELG | Exit | CELGENEput | $0 | – | -525,000 | -100.0% | -34.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.